{"nctId":"NCT00930644","briefTitle":"Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)","startDateStruct":{"date":"2009-09-21","type":"ACTUAL"},"conditions":["Short Bowel Syndrome"],"count":88,"armGroups":[{"label":"teduglutide","type":"EXPERIMENTAL","interventionNames":["Drug: teduglutide"]}],"interventions":[{"name":"teduglutide","otherNames":["Gattex"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* must have completed 24 weeks of dosing of the CL0600-020 study\n\nExclusion Criteria:\n\n* none","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change in PN/IV Volume by Visit","description":"The mean change from baseline in weekly PN.IV volume in percent change is shown by visit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.35","spread":"11.287"},{"groupId":"OG001","value":"-6.44","spread":"11.241"},{"groupId":"OG002","value":"-40.65","spread":"21.546"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.88","spread":"22.789"},{"groupId":"OG001","value":"-10.27","spread":"14.027"},{"groupId":"OG002","value":"-44.24","spread":"21.823"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.83","spread":"47.396"},{"groupId":"OG001","value":"-14.18","spread":"16.440"},{"groupId":"OG002","value":"-45.80","spread":"22.681"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.13","spread":"17.496"},{"groupId":"OG001","value":"-16.48","spread":"20.979"},{"groupId":"OG002","value":"-34.70","spread":"55.319"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-25.35","spread":"17.855"},{"groupId":"OG001","value":"-20.95","spread":"27.500"},{"groupId":"OG002","value":"-37.91","spread":"57.460"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-23.33","spread":"20.296"},{"groupId":"OG001","value":"-22.00","spread":"33.858"},{"groupId":"OG002","value":"-51.33","spread":"28.299"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.62","spread":"25.901"},{"groupId":"OG001","value":"-18.89","spread":"33.165"},{"groupId":"OG002","value":"-54.24","spread":"27.871"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-35.11","spread":"35.545"},{"groupId":"OG001","value":"-24.18","spread":"32.183"},{"groupId":"OG002","value":"-63.01","spread":"26.587"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-39.40","spread":"36.504"},{"groupId":"OG001","value":"-27.67","spread":"33.064"},{"groupId":"OG002","value":"-64.99","spread":"27.920"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-39.40","spread":"36.504"},{"groupId":"OG001","value":"-28.33","spread":"35.169"},{"groupId":"OG002","value":"-65.61","spread":"33.606"}]}]}]},{"type":"PRIMARY","title":"Absolute Change in PN/IV Volume by Visit","description":"The mean change from baseline in weekly PN.IV volume in Liters is shown by visit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.05","spread":"1.315"},{"groupId":"OG001","value":"-0.95","spread":"1.938"},{"groupId":"OG002","value":"-5.28","spread":"3.819"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.88","spread":"2.057"},{"groupId":"OG001","value":"-1.38","spread":"2.228"},{"groupId":"OG002","value":"-5.62","spread":"3.873"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.55","spread":"3.123"},{"groupId":"OG001","value":"-1.65","spread":"2.456"},{"groupId":"OG002","value":"-5.72","spread":"3.771"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.85","spread":"2.761"},{"groupId":"OG001","value":"-1.90","spread":"3.309"},{"groupId":"OG002","value":"-5.20","spread":"4.650"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.69","spread":"2.916"},{"groupId":"OG001","value":"-2.61","spread":"4.071"},{"groupId":"OG002","value":"-5.59","spread":"4.899"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.90","spread":"2.762"},{"groupId":"OG001","value":"-2.72","spread":"4.310"},{"groupId":"OG002","value":"-6.36","spread":"4.633"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.58","spread":"2.811"},{"groupId":"OG001","value":"-2.48","spread":"4.398"},{"groupId":"OG002","value":"-6.37","spread":"4.261"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.63","spread":"2.834"},{"groupId":"OG001","value":"-2.90","spread":"4.394"},{"groupId":"OG002","value":"-6.99","spread":"4.048"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.01","spread":"2.910"},{"groupId":"OG001","value":"-3.00","spread":"3.571"},{"groupId":"OG002","value":"-7.34","spread":"4.412"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.01","spread":"2.910"},{"groupId":"OG001","value":"-3.11","spread":"3.880"},{"groupId":"OG002","value":"-7.55","spread":"4.930"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Achieving PN/IV Reduction","description":"The number of subjects who achieve at least 1-, 2-, and 3-day reductions in PN/IV per Week.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"14","spread":null},{"groupId":"OG002","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"18","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":32,"n":51},"commonTop":["Infections and Infestations","Gastrointestinal Disorders","General Disorders, and Administration Site Conditions","Investigations","Injury, Poisoning, and Procedural Complications"]}}}